Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, May 18, 2022
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
[ Wed, May 18th 2022
] - WOPRAI
Tue, May 17, 2022
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
Matthew Harrison Maintained (TSVT) at Buy with Decreased Target to $31 on, May 17th, 2022
Matthew Harrison of Morgan Stanley, Maintained "2seventy bio, Inc." (TSVT) at Buy with Decreased Target from $36 to $31 on, May 17th, 2022.
Matthew has made no other calls on TSVT in the last 4 months.
There are 2 other peers that have a rating on TSVT. Out of the 2 peers that are also analyzing TSVT, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Matthew
- Salveen Richter of "Goldman Sachs" Initiated at Strong Buy and Held Target at $26 on, Monday, May 2nd, 2022
- Daina Graybosch of "SVB Leerink" Initiated at Buy and Held Target at $38 on, Thursday, February 10th, 2022
